These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 20658466)

  • 41. Nonalcoholic fatty liver disease predicts chronic kidney disease in nonhypertensive and nondiabetic Korean men.
    Chang Y; Ryu S; Sung E; Woo HY; Oh E; Cha K; Jung E; Kim WS
    Metabolism; 2008 Apr; 57(4):569-76. PubMed ID: 18328362
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Circulating gamma glutamyltransferase and prediction of cardiovascular disease.
    Kunutsor SK; Bakker SJ; Kootstra-Ros JE; Gansevoort RT; Dullaart RP
    Atherosclerosis; 2015 Feb; 238(2):356-64. PubMed ID: 25555268
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients.
    Targher G; Bertolini L; Padovani R; Rodella S; Tessari R; Zenari L; Day C; Arcaro G
    Diabetes Care; 2007 May; 30(5):1212-8. PubMed ID: 17277038
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Markers of the hepatic component of the metabolic syndrome as predictors of mortality in renal transplant recipients.
    Zelle DM; Corpeleijn E; van Ree RM; Stolk RP; van der Veer E; Gans RO; Homan van der Heide JJ; Navis G; Bakker SJ
    Am J Transplant; 2010 Jan; 10(1):106-14. PubMed ID: 19951280
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Gamma-glutamyltransferase is associated with incident vascular events independently of alcohol intake: analysis of the British Women's Heart and Health Study and Meta-Analysis.
    Fraser A; Harris R; Sattar N; Ebrahim S; Smith GD; Lawlor DA
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2729-35. PubMed ID: 17932318
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Correlation between nonalcoholic fatty liver and cardiovascular disease in elderly hemodialysis patients.
    Stolic RV; Trajkovic GZ; Kostic MM; Sovtic SR; Odalovic AM; Krdzic BD; Sipic MV; Lazic S; Sojevic-Timotijevic ZN
    Int Urol Nephrol; 2016 Jun; 48(6):883-9. PubMed ID: 26905407
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Serum gamma-glutamyltransferase within its normal concentration range is related to the presence of diabetes and cardiovascular risk factors.
    Kim DJ; Noh JH; Cho NH; Lee BW; Choi YH; Jung JH; Min YK; Lee MS; Lee MK; Kim KW
    Diabet Med; 2005 Sep; 22(9):1134-40. PubMed ID: 16108838
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Extrahepatic complications of nonalcoholic fatty liver disease.
    Armstrong MJ; Adams LA; Canbay A; Syn WK
    Hepatology; 2014 Mar; 59(3):1174-97. PubMed ID: 24002776
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Functional and morphological vascular changes in pediatric nonalcoholic fatty liver disease.
    Pacifico L; Anania C; Martino F; Cantisani V; Pascone R; Marcantonio A; Chiesa C
    Hepatology; 2010 Nov; 52(5):1643-51. PubMed ID: 20890890
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effects of 8 months of metformin on circulating GGT and ALT levels in obese women with polycystic ovarian syndrome.
    Preiss D; Sattar N; Harborne L; Norman J; Fleming R
    Int J Clin Pract; 2008 Sep; 62(9):1337-43. PubMed ID: 18565127
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Nonalcoholic fatty liver disease as a potential risk factor of cardiovascular disease.
    Luo J; Xu L; Li J; Zhao S
    Eur J Gastroenterol Hepatol; 2015 Mar; 27(3):193-9. PubMed ID: 25563143
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Large-scale analysis of factors influencing nonalcoholic fatty liver disease and its relationship with liver enzymes.
    Bi WR; Yang CQ; Shi Q; Xu Y; Cao CP; Ling J; Wang XY
    Genet Mol Res; 2014 Aug; 13(3):5880-91. PubMed ID: 25117346
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Indicators of fetal growth and adult liver enzymes: the Bogalusa Heart Study and the Cardiovascular Risk in Young Finns Study.
    Harville EW; Chen W; Bazzano L; Oikonen M; Hutri-Kähönen N; Raitakari O
    J Dev Orig Health Dis; 2017 Apr; 8(2):226-235. PubMed ID: 27919310
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The pilot study of 3-month course of melatonin treatment of patients with nonalcoholic steatohepatitis: effect on plasma levels of liver enzymes, lipids and melatonin.
    Gonciarz M; Gonciarz Z; Bielanski W; Mularczyk A; Konturek PC; Brzozowski T; Konturek SJ
    J Physiol Pharmacol; 2010 Dec; 61(6):705-10. PubMed ID: 21224501
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ectopic fat, insulin resistance, and nonalcoholic fatty liver disease: implications for cardiovascular disease.
    Byrne CD; Targher G
    Arterioscler Thromb Vasc Biol; 2014 Jun; 34(6):1155-61. PubMed ID: 24743428
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Gamma-glutamyltransferase as a risk factor for cardiovascular disease mortality: an epidemiological investigation in a cohort of 163,944 Austrian adults.
    Ruttmann E; Brant LJ; Concin H; Diem G; Rapp K; Ulmer H;
    Circulation; 2005 Oct; 112(14):2130-7. PubMed ID: 16186419
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Nonalcoholic fatty liver disease and risk of future cardiovascular events among type 2 diabetic patients.
    Targher G; Bertolini L; Poli F; Rodella S; Scala L; Tessari R; Zenari L; Falezza G
    Diabetes; 2005 Dec; 54(12):3541-6. PubMed ID: 16306373
    [TBL] [Abstract][Full Text] [Related]  

  • 58. High prevalence of elevated liver enzymes in blood donors: associations with male gender and central adiposity.
    Papatheodoridis GV; Goulis J; Christodoulou D; Manolakopoulos S; Raptopoulou M; Andrioti E; Alexandropoulos N; Savvidou S; Papachristou A; Zervou E; Seferiadis K; Kousidou P; Vogiatzakis E; Tsianos E
    Eur J Gastroenterol Hepatol; 2007 Apr; 19(4):281-7. PubMed ID: 17353691
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Association of nonalcoholic fatty liver disease with type 2 diabetes: clinical features and independent risk factors in diabetic fatty liver patients.
    Jin HB; Gu ZY; Yu CH; Li YM
    Hepatobiliary Pancreat Dis Int; 2005 Aug; 4(3):389-92. PubMed ID: 16109522
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Liver Enzymes and Risk of Ischemic Heart Disease and Type 2 Diabetes Mellitus: A Mendelian Randomization Study.
    Liu J; Au Yeung SL; Lin SL; Leung GM; Schooling CM
    Sci Rep; 2016 Dec; 6():38813. PubMed ID: 27996050
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.